Natco Pharma aims to diversify product portfolio in domestic market
Informing shareholders, the drug maker said its oncology segment suffered in the last financial year due to pricing controls from the government, and its Hepatitis-C business continued to decline due to reduction in market size. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 21, 2020 Category: Pharmaceuticals Source Type: news

HCV-Related Liver Cancer Incidence Dropped in US Cohort HCV-Related Liver Cancer Incidence Dropped in US Cohort
The incidence of hepatocellular carcinoma declined after widespread use of direct-acting antiviral therapies to treat hepatitis C, according to findings from a large population-based study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 16, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Steatohepatitis Biomarkers and HCC After HCV Elimination Steatohepatitis Biomarkers and HCC After HCV Elimination
This study used steatohepatitis-related biomarkers to evaluate the development of hepatocellular carcinoma by patients with chronic hepatitis C who achieved SVR by DAA treatment.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 9, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

New Approach Allows Safe Transplant of Kidneys Tainted by Hepatitis C
TUESDAY, Sept. 8, 2020 -- New hepatitis C medications are allowing people to receive a kidney transplant from a deceased donor who had the liver disease -- a strategy aimed at getting more lifesaving organs to patients languishing on waitlists. Two... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 8, 2020 Category: General Medicine Source Type: news

New Approach Allows Safe Transplant of Kidneys Tainted by Hepatitis C
Title: New Approach Allows Safe Transplant of Kidneys Tainted by Hepatitis CCategory: Health NewsCreated: 9/8/2020 12:00:00 AMLast Editorial Review: 9/8/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - September 8, 2020 Category: Nutrition Source Type: news

Hepatitis C service specification published
The community pharmacy Hepatitis C Antibody Testing advanced service went live on 1 September 2020. Through this service, people who inject drugs and who are not currently accessing community drug and alcohol treatment services can be tested for the hepatitis C virus at a participating community pharmacy. (Source: NHS Networks)
Source: NHS Networks - September 8, 2020 Category: UK Health Source Type: news

Many Advanced Countries Missing Targets for HCV Elimination Many Advanced Countries Missing Targets for HCV Elimination
The World Health Organization wants to eliminate hepatitis C infection by the end of the decade. Researchers performed disease progression models of HCV infection in 45 high-income countries.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 4, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Hepatitis C Treatments Give Patients More Options
Advances in drug treatments approved by the Food and Drug Administration (FDA) are giving the 3.2 million Americans with chronic hepatitis C a chance at a longer, healthier life. That's welcome news for baby boomers, a generation that makes up three of four adults with the hepatitis C virus. (Source: FDA Consumer Health Information Updates)
Source: FDA Consumer Health Information Updates - September 2, 2020 Category: Consumer Health News Authors: FDA Source Type: news

Los tratamientos contra la hepatitis C dan a los pacientes m ás opciones
Los adelantos en los tratamientos con medicamentos aprobados por la Administraci ón de Alimentos y Medicamentos (FDA) están dando a los 3.2 millones de estadounidenses que viven con hepatitis C la oportunidad de vivir una vida más larga y saludable. Los llamados “baby boomers”, la generación cerca a la edad de jubilación y que son tres de cada cuatro portadores del viru s de la hepatitis C, reciben la noticia con júbilo. (Source: FDA Consumer Health Information Updates)
Source: FDA Consumer Health Information Updates - September 2, 2020 Category: Consumer Health News Authors: FDA Source Type: news

Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020
This report describes a funding program in Uzbekistan designed to identify and treat cases of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection at a lowered cost with the goal of meeting the World Health Organization's targets to eliminate HBC and HCV infection. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - August 27, 2020 Category: American Health Tags: Hepatitis B Hepatitis C MMWR Morbidity & Mortality Weekly Report Source Type: news

New models help predict liver cancer after successful hepatitis C virus (HCV) treatment
(Spink Health) Digital ILC 2020: European scientists develop new predictive models for HCC in patients with chronic HCV after a sustained virological response to direct-acting antiviral therapy (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 26, 2020 Category: Cancer & Oncology Source Type: news

6th Circuit: OK to ration hepatitis C treatment to prisoners
In a split decision, a panel of the 6th U.S. Circuit Court of Appeals has upheld Tennessee’s rationing of life-saving hepatitis C drugs to prisoners as constitutional (Source: ABC News: Health)
Source: ABC News: Health - August 25, 2020 Category: Consumer Health News Tags: Health Source Type: news

Routine hepatitis C testing saves long-term expenditure
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2020 Category: Drugs & Pharmacology Source Type: news

NHS Tayside claims it has 'effectively eliminated' hepatitis C
NHS Tayside targeted injecting drug users in a bid to eradicate the blood borne virus. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - July 28, 2020 Category: Consumer Health News Source Type: news

Viral hepatitis: Europe needs to close the testing gap
(European Centre for Disease Prevention and Control (ECDC)) Approximately four in five people living with hepatitis B and three out of four people with hepatitis C infection across the European Union and European Economic Area (EU/EEA) and the UK have not yet been diagnosed. This is a major obstacle on the way towards the Sustainable Development Goal (SDG) for health in 2030 as highlighted by ECDC on occasion of World Hepatitis Day. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 27, 2020 Category: Infectious Diseases Source Type: news

Trial finds drug safe and effective in treating hep-c during pregnancy
(University of Pittsburgh) Critics of the universal hepatitis C screening argue that it's wasteful to test pregnant women for a disease that can't be immediately treated, but results of a small phase I clinical trial suggest otherwise: pregnancy could be an excellent time to diagnose and cure hepatitis C infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 27, 2020 Category: Infectious Diseases Source Type: news

Barriers to Hepatitis C Screening and Linkage to Care Barriers to Hepatitis C Screening and Linkage to Care
This study aimed to identify patient and provider barriers that contribute to suboptimal HCV screening and linkage-to-care. What opportunities exist to improve HCV screening and treatment delivery?Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 24, 2020 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

New CDC Guidance for Healthcare Personnel Exposed to HCV New CDC Guidance for Healthcare Personnel Exposed to HCV
New recommendations from the CDC offer guidance for postexposure testing and clinical management of healthcare personnel exposed to hepatitis C virus.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 23, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Recommendations and Reports: Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus - CDC Guidance, United States, 2020
This report describes updated guidance for laboratory testing and follow-up of healthcare personnel who have been potentially exposed to hepatitis C virus as well as recommended treatment of acute hepatitis C virus infection. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 23, 2020 Category: American Health Tags: Hepatitis C Infection MMWR Morbidity & Mortality Weekly Report Prevention Infection Control Source Type: news

Closing the gap: finding undiagnosed hepatitis C infections after blood transfusions
(European Centre for Disease Prevention and Control (ECDC)) What is the incidence of viral hepatitis caused by blood transfusions before and after Sweden introduced screening of blood in the early 1990s? In an article published in Eurosurveillance ahead of World Hepatitis Day on 28 July, the authors also try to estimate how many people of those who were infected with hepatitis B and C through blood transfusion still live with undiagnosed hepatitis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 23, 2020 Category: Infectious Diseases Source Type: news

Hepatitis C drug can help improve condition of coronavirus patients: Study
Though there was no change in recovery time, the researchers also found that the interferon therapy if administered after five days of hospitalisation resulted in increased deaths. (Source: The Economic Times)
Source: The Economic Times - July 23, 2020 Category: Consumer Health News Source Type: news

Routine Hepatitis C Testing at FQHCs Would Be Cost-Effective
WEDNESDAY, July 22, 2020 -- Routine hepatitis C virus (HCV) testing at federally qualified health centers (FQHCs) would be cost-effective and could improve outcomes for people with HCV infections, according to a study published online June 27 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 22, 2020 Category: Pharmaceuticals Source Type: news

HCC in Chronic HCV Patients Who Achieved SVR HCC in Chronic HCV Patients Who Achieved SVR
Does achieving SVR with DAAs reduce the incidence of hepatocellular carcinoma in chronic hepatitis C patients, genotype IV with liver cirrhosis and advanced hepatic fibrosis?Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 17, 2020 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

HIV Infection May Impact Sensitivity of Rapid Diagnostic Tests for HCV HIV Infection May Impact Sensitivity of Rapid Diagnostic Tests for HCV
Hepatitis C virus rapid diagnostic tests had variable sensitivity in patients with HIV, in a multinational retrospective study.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 14, 2020 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Cancer Clinical Trial Eligibility Criteria: Patients with HIV, Hepatitis B Virus, or Hepatitis C Virus Infections
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 10, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

RCTs Towards a Single-visit Cure for Chronic Hepatitis C RCTs Towards a Single-visit Cure for Chronic Hepatitis C
This study evaluated the safety and feasibility of a single-visit cure for chronic hepatitis C using a combination of two novel agents.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 10, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Hepatitis C drugs help combat Covid-19 in trials
US official Anthony Fauci says sofosbuvir and daclatasvir results are ‘provocative and encouraging’ (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 9, 2020 Category: Pharmaceuticals Source Type: news

Hepatitis C management at federally qualified health centers proves cost-effective
(Boston Medical Center) BOSTON- New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers (FQHC) improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective. The formerly recommended targeted testing approach was shown to provide worse outcomes at a higher cost when compared to routine testing. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 8, 2020 Category: Infectious Diseases Source Type: news

Updated Guidance Provided for Safe Solid Organ Transplantation
TUESDAY, June 30, 2020 -- Updated recommendations for reducing transmission of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) through transplantation include universal solid organ donor nucleic acid testing, according to research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 30, 2020 Category: Pharmaceuticals Source Type: news

RECOMMENDATIONS and REPORTS: Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020
This report describes the June 2020 U.S. Public Health Service guidelines which recommend actions healthcare providers can take before and after transplant to minimize the risk of infection (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 25, 2020 Category: American Health Tags: Hepatitis Hepatitis B Hepatitis C HIV/AIDS MMWR Morbidity & Mortality Weekly Report Organ Transplants Source Type: news

Study finds HCV-positive livers safe for transplantation; Patients cured afterward
(University of Cincinnati) UC researchers find similar results for positive outcomes when comparing patients receiving livers infected with hepatitis C to patients who receive livers without infection. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2020 Category: International Medicine & Public Health Source Type: news

Virus co-opts immune protein to avoid antiviral defences
(eLife) By discovering a trick the hepatitis C virus uses to evade the immune system, scientists have identified a new antiviral defence system that could be used to treat many virus infections, according to new research published today in eLife. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 16, 2020 Category: International Medicine & Public Health Source Type: news

Will anything come of AstraZeneca's rumored interest in merging with Gilead? Not likely
Cold water washed over Wall Street talk of a proposed merger between Gilead Sciences Inc. and AstraZeneca plc. AstraZeneca approached Gilead last month about a possible deal, Bloomberg reported, but the companies reportedly aren't in formal talks. What's more, analysts said a deal was unlikely to occur. A deal would link the United Kingdom's biggest drugmaker (NYSE: AZN) and one of the largest biotech co mpanies (NASDAQ: GILD) that has changed the landscape of HIV, hepatitis C and, potentially,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 8, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Newly Reported Acute and Chronic HCV Cases: US, 2009-2018 Newly Reported Acute and Chronic HCV Cases: US, 2009-2018
This report highlights the epidemic of hepatitis C among US adults, and supports CDC's new screening recommendations to screen all adults for this curable disease.Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - May 22, 2020 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news

Tip of the iceberg: Existing racial inequalities in death from COVID-19 will soar
(Florida Atlantic University) Lifesaving innovations for COVID-19 will only markedly increase the already existing racial inequalities, if public health initiatives for equitable dissemination throughout all communities are not immediately developed. The introduction of drugs for HIV, respiratory distress syndrome, and hepatitis C resulted in racial inequalities. Moreover, before the introduction of the Salk polio vaccine in 1952, initially, black Americans experienced significantly lower rates of paralytic polio than white Americans. By 1959, after the widespread distribution of the vaccine, the reverse was true. (Source:...
Source: EurekAlert! - Infectious and Emerging Diseases - May 20, 2020 Category: Infectious Diseases Source Type: news

What Are Potential Complications of Tattooing?
Discussion “Tattooing of skin via deposition of pigment particles and ink ingredients in the dermis changes normal skin into abnormal skin. Fortunately, this often causes no harm and no disease, although with important exceptions.” Tattoos can be inadvertent from road dirt, gunpowder, pencil graphite etc., but most are desired. Tattoos are common in many cultures and over time..They have been increasing in popularity in the United States over the past few years particularly with a younger, wider and more diverse population. Newsweek reported an 18-country study in 2018 which showed 46% of Americans have a tat...
Source: PediatricEducation.org - May 18, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Opt-Out Universal Hep C Screening in Emergency Dept Is Useful
THURSDAY, May 14, 2020 -- Emergency department opt-out universal hepatitis C virus (HCV) screening can identify a large number of unrecognized HCV infections, including among those born after 1965, according to research published in the May 15 issue... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 14, 2020 Category: Pharmaceuticals Source Type: news

High Prevalence of Hepatitis C Infection Among Adult Patients at Four Urban Emergency Departments --- Birmingham, Oakland, Baltimore, and Boston, 2015--2017
This report describes a new study that found universal hepatitis C testing in emergency departments identified a greater number of previously unrecognized infections, especially in persons born after 1965. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - May 14, 2020 Category: American Health Tags: Hepatitis C MMWR Morbidity & Mortality Weekly Report Source Type: news

Abbott Labs gets FDA emergency authorization for another Covid-19 test
Abbott Laboratories said it's received an emergency use authorization from the U.S. Food and Drug Administration for another test for Covid-19. The latest Abbott Labs (NYSE: ABT) test is its new "Alinity m" molecular laboratory instrument, which was cleared by the FDA for use with its hepatitis C test in late March. The company said "Alinity m" improves speed and efficiency and can run up to 1,080 Covid-19 tests in 24 hours. "Molecular l ab tests play a critical role in detecting the virus for Covid-19.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 12, 2020 Category: Pharmaceuticals Authors: Ben Miller Source Type: news

Racial Inequalities of Liver Cancer Mortality Increase After Introduction of Hepatitis C Drugs
Researchers found a steady increase in racial inequalities of the mortality rate from liver cancer from 1998-2016 after lifesaving drugs for hepatitis C virus were introduced. (Source: CancerNetwork)
Source: CancerNetwork - May 11, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news

Combination of HIV, hepatitis C, MS drugs might resolve COVID-19 infection
Combination therapy with interferon beta-1b plus lopinavir-ritonavir and ribavirin appears to improve symptoms and shorten hospital stays for people with mild to moderate COVID-19. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 9, 2020 Category: Consumer Health News Source Type: news

Supercomputer Simulations Present Potential Active Substances Against Coronavirus
Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research based on extensive calculations using the MOGON II supercomputer at Johannes Gutenberg University Mainz (JGU). One of the most powerful computers in the world, (Source: eHealth News EU)
Source: eHealth News EU - May 5, 2020 Category: Information Technology Tags: Featured Research Research and Development Source Type: news

Supercomputer simulations present potential active substances against coronavirus
Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research based on extensive calculations using the MOGON II supercomputer at Johannes Gutenberg University Mainz (JGU). One of the most powerful computers in the world, (Source: World Pharma News)
Source: World Pharma News - May 5, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Supercomputer simulations present potential active substances against coronavirus
(Johannes Gutenberg Universitaet Mainz) Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research based on extensive calculations using the MOGON II supercomputer at Johannes Gutenberg University Mainz (JGU). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 5, 2020 Category: Infectious Diseases Source Type: news

Bringing Point-of-Care Testing to Consumer End-Points
The medical diagnostics industry has been moving steadily from centralized testing toward a decentralized model that brings testing ever closer to the patient. The benefits of point-of-care (POC) interventions are significant, and new technologies have expanded the options of home testing, while new generations of testing kits offer enhanced accuracy, reliability, and speed. Detection and monitoring are especially critical for diseases such as HIV, Hepatitis C (HVC), and colon cancer, and POC technologies can encourage early detection and better testing compliance as they are more accessible for patients. They are also les...
Source: MDDI - May 5, 2020 Category: Medical Devices Authors: Maria De Capua Tags: IVD Source Type: news

Hepatitis C drugs may help fight COVID-19, supercomputer simulations suggest
Researchers from Johannes Gutenberg University Mainz (JGU) in Germany simulated the way that about 42,000 different substances listed in open databases bind to certain proteins of SARS-CoV-2, and thereby inhibit the penetration of the virus into the human body or its multiplication. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2020 Category: Pharmaceuticals Source Type: news

Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment Guidance for Industry
Clinical / Antimicrobial (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 4, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Inventor of Hepatitis C cure receives prestigious University of Edinburgh prize
(University of Edinburgh) A medicinal chemist who found a cure for the viral disease hepatitis C has received a prestigious award from the University of Edinburgh. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 1, 2020 Category: Infectious Diseases Source Type: news

Racial inequalities in liver cancer deaths soared after launch of hepatitis C drugs
(Florida Atlantic University) Before and after the introduction of lifesaving drugs for hepatitis C, researchers found that from 1979 to 1998, racial inequalities in mortality from liver cancer in the US were declining. But, from 1998 to 2016, of the 16,770 deaths from liver cancer among blacks, the excess relative to whites increased from 27.8 percent to 45.4 percent. Concurrently, racial inequalities in death decreased for major risk factors for liver cancer, such as alcohol, obesity and diabetes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 30, 2020 Category: Cancer & Oncology Source Type: news

New findings on hepatitis C in infants can lead to improved treatments
(Karolinska Institutet) Only about 5% of the babies born to mothers with hepatitis C are themselves infected by the disease. A possible reason for this low figure is that the baby's immune system has already destroyed the virus before birth. A new study from researchers at Karolinska Institutet published in the journal Gut reveals clear adaptations of the uninfected babies' immune system that can lead the way to new treatment methods. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 27, 2020 Category: Infectious Diseases Source Type: news